Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03452917 · ClinicalTrials.gov registry record · Phase 2
Clinical Trial of Sodium Nitrite for Out of Hospital Cardiac Arrest
A Phase 2 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,502
- Enrollment target
NCT03452917: Completed Phase 2 study, sponsored by University of Washington.
NCT03452917 is a Phase 2 study that has completed, run by University of Washington. The registered enrollment target is 1,502 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (1029% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03452917, a Phase 2 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,502 participants
- Enrollment target
Study Summary
In this clinical study, a total of 1500 patients with out-of-hospital cardiac arrest in Seattle/King County will be enrolled. This will be a randomized clinical trial and patients will receive either two different doses of IV sodium nitrite (45 mg or 60 mg) or placebo during resuscitation in the field by paramedics. The primary outcome will be proportion of patients surviving to hospital admission.
Primary Outcome
Patient has sustained pulse at arrival to the emergency department
Interventions
- DRUG Placebo
- DRUG sodium nitrite 45 mg
- DRUG sodium nitrite 60 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,502 participants |
| Start Date | 2018-02-08 |
| Est. Completion | 2020-04-30 |
| Phase | Phase 2 |
What the finished NCT03452917 record still lists
NCT03452917 is an interventional study that assigns participants to a tested intervention. Its 1,502 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (1029% higher).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT03452917 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03452917 about?
NCT03452917 is a clinical study titled "Clinical Trial of Sodium Nitrite for Out of Hospital Cardiac Arrest". In this clinical study, a total of 1500 patients with out-of-hospital cardiac arrest in Seattle/King County will be enrolled. This will be a randomized clinical trial and patients will receive either two different doses of IV sodium nitrite (45 mg or 60 mg) or placebo during resuscitation in the fie...
What is the current status of trial NCT03452917?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,502 participants. The study started on 2018-02-08. Estimated completion is 2020-04-30.
What interventions are being tested in trial NCT03452917?
The interventions under investigation include: Placebo (DRUG), sodium nitrite 45 mg (DRUG), sodium nitrite 60 mg (DRUG).
Who is sponsoring clinical trial NCT03452917?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03452917's enrollment target sits among peer trials
1,502 11th of 2000 higher than 1,990 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI